$0.72
▼ -2.7% Today
as of Jul 22, 16:50 ET
Last 30 days
Recent Press Releases & News
Jasper gets a lifeline in merger with immune drugmaker Kira
Jasper Therapeutics Completes Merger With Kira Pharmaceuticals, Shares Fall
Jasper Therapeutics Announces Merger with Kira Pharmaceuticals
Overview
52-week range
$0.43
$7.19
4% of range
Avg surprise (last 3)
-16.0%
Avg reaction (last 2)
+4.6%
100% positive
Latest IV / EM
2186%
EM ±500.0% · $3 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 14, 2026 | Mar/2026 | $-0.38 | $-0.46 | +17.4% | +73.0% | +4.2% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-1.13 | — | — | — | — | financials |
| Wed Aug 13, 2025 | Jun/2025 | $-1.74 | $-1.20 | -45.0% | — | — | earnings |
| Mon May 12, 2025 | Mar/2025 | $-1.41 | $-1.17 | -20.5% | — | +4.9% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-1.24 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.97 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-1.03 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-1.60 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-1.47 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Wed Aug 12, 2026 | Jun/2026 | OTHER | -$0.38 | -$1.74 | +78.2% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | $4M | — | $9M | — | $10M | — | $9M | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-11M | — | $-19M | $-27M | $-22M | — | $-20M | $-16M |
| Net income | $-1M | — | $-19M | $-27M | $-21M | — | $-19M | $-15M |
| EPS (diluted) | $-0.04 | — | $-1.13 | $-1.74 | $-1.41 | — | $-1.24 | $-0.97 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $14M | $29M | $51M | $40M | $49M | $72M | $93M | $107M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $20M | $35M | $55M | $43M | $53M | $76M | $95M | $109M |
| Total assets | $21M | $36M | $57M | $46M | $58M | $80M | $99M | $114M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $18M | $32M | $46M | $23M | $15M | $18M | $16M | $14M |
| Total equity | $3M | $4M | $12M | $24M | $42M | $62M | $84M | $100M |